ID   OGU1
AC   CVCL_4664
DR   CLO; CLO_0050008
DR   BioSample; SAMN03471968
DR   RCB; RCB2351
DR   Wikidata; Q54931880
RX   PubMed=25846106;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=25846106).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB2351
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
RX   PubMed=25846106; DOI=10.1111/ejh.12559;
RA   Kawauchi, Kiyotaka
RA   Ogasawara, Toshie
RA   Aiba, Motohiko
RA   Fujibayashi, Mariko
RA   Sanaka, Tsutomu
RA   Sakura, Hiroshi
RA   Shibuya, Masabumi
RT   "Establishment and characterization of a novel VEGF-producing
RT   HHV-8-unrelated PEL-like lymphoma cell line, OGU1.";
RL   Eur. J. Haematol. 96:144-151(2016).
//